P53 Immunohistochemistry (IHC) Staining Status in Endometrial Carcinoma
Percentage of final pathology reports for endometrial biopsy, dilation and curettage (D&C) material, or hysterectomy specimen with an initial diagnosis of primary endometrial carcinoma that contain the results of P53 immunohistochemistry (IHC) staining.
Percentage of final pathology reports for endometrial biopsy, dilation and curettage (D&C) material, or hysterectomy specimen with an initial diagnosis of primary endometrial carcinoma that contain the results of P53 immunohistochemistry (IHC) staining.